𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness analysis of the Lyme disease vaccine

✍ Scribed by Elizabeth C. Hsia; James B. Chung; J. Sanford Schwartz; Daniel A. Albert

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
131 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evaluating the cost-effectiveness of vac
Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective
✍ W. J. Edmunds; G. F. Medley; D. J. Nokes πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 213 KB πŸ‘ 2 views

Although there are many models which are used to calculate the health bene"ts (and thus the coste!ectiveness) of vaccination programmes, they can be divided into two groups: those which assume a constant force of infection, that is a constant per-susceptible rate of infection; and those which assume

Treatment of Guillain-BarrΓ© syndrome: A
Treatment of Guillain-BarrΓ© syndrome: A cost-effectiveness analysis
✍ Seema Nagpal; Tim Benstead; Kenneth Shumak; Gail Rock; Murray Brown; David R. An πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 59 KB

Acute Guillain-Barre Β΄syndrome is the most common cause of neuromuscular paralysis. Plasma exchange and intravenous immune globulin (IV IgG) are both effective treatments for this condition and the purpose of this report was to compare the cost-effectiveness of these two modalities. A MEDLINE search